ANTHRAX-ANTIGENE UND ANWENDUNGSVERFAHREN

European patent · EP1735338 · Deleted

Register entry

Publication number
EP1735338
Application number
EP05758632
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Feb 11, 2005
Published
Dec 27, 2006
Granted
Apr 24, 2013
Deleted
Feb 28, 2019
Reason
Annual fee unpaid
IPC classes
A61K 39/395 (2006.01)
C07H 21/00 (2006.01)
A61K 39/00 (2006.01)
C07H 21/02 (2006.01)
A61K 39/07 (2006.01)
C12N 9/54 (2006.01)
C07H 19/00 (2006.01)
C12P 21/04 (2006.01)
Priority
US 544130 P 11.02.2004
US 544848 P 12.02.2004
PCT application
PCT/US2005/004678 11.02.2005
PCT publication
WO2005/086637 22.09.2005
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 18, 2019

    Deleted, fee unpaid

    Published in Swissreg on 18.09.2019

  2. Nov 7, 2018

    Address changed

    Representative
    Frei Patentanwaltsbüro AG, Postfach 1771, 8032 Zürich → Frei Patentanwaltsbüro AG, Postfach, 8032 Zürich

    Published in Swissreg on 07.11.2018

  3. Apr 1, 2014

    Merged

    Owner
    Takeda Vaccines (Montana), Inc., 2155 Analysis Drive, Bozeman, MT 59718-6831, USA → Takeda Vaccines, Inc., 2155 Analysis Drive, Bozeman, MT 59718-6831, USA

    Published in Swissreg on 01.04.2014

  4. Jul 11, 2013

    Agent entered

    Representative
    Frei Patentanwaltsbüro AG, Postfach 1771, 8032 Zürich

    Published in Swissreg on 11.07.2013

  5. Apr 24, 2013

    Granted

    Published in Swissreg on 24.04.2013

Parties

Holder

Takeda Vaccines, Inc.

2155 Analysis Drive, Bozeman, MT 59718-6831, US

Agent

Frei Patentanwaltsbüro AG

Postfach, 8032 Zürich

Inventor

WIMER-MACKIN, Susan

Bozeman, MT 59715, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.